Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms

Neuroendocrine Tumors

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

Esophageal Squamous Cell Carcinoma

Squamous Cell Carcinoma of Head and Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Squamous Cell Carcinoma of Head and Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms, Inflammatory Breast Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

Various Advanced Cancer

Lymphoma, Mantle-Cell

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Pentoxifylline, Cisplatin, Nephrotoxixcity

Mesothelioma, Malignant, Mesothelioma

Parkinson Disease 4, Autosomal Dominant Lewy Body

Parkinson Disease 4, Autosomal Dominant Lewy Body, Urinary Bladder Neoplasms

Carcinoma, Non-Small-Cell Lung

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

Carcinoma, Non-Small-Cell Lung

Locally Advanced Non-Small Cell Lung Cancer

Medulloblastoma

Neuroblastoma, Ganglioneuroblastoma

Mesothelioma, Malignant

Non-Small-Cell Lung

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Mesothelioma, Malignant, Mesothelioma

Lymphoma, Mantle-Cell

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Precancerous Conditions, Papillomavirus Infections

Nasopharyngeal Carcinoma

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Uterine Cervical Neoplasms

Clinical Trials

Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery

Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer

KEYNOTE-585

Adjuvant Pembrolizumab for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma at High Risk of Recurrence

Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer

Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

A Phase I Comparative Study of Pharmacokinetics, Safety, and Efficacy of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma

Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006)

Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)

Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer

KEYNOTE-A18

CheckMate 648

BDH-MCL01

Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung Cancer

Intratumoral Cisplatin for Resectable NSCLC

Nephroprotective Effect of Pentoxifylline Against Cisplatin in Patients With Head and Neck Cancer

MesoPDT

LEAP-006

KEYNOTE-B15

MK-7684A-007

KEYNOTE-412

KEYNOTE-826

SKYSCRAPER-06

ARCADIAN

Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma

Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin

CheckMate 6DW

A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)

Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC)

DREAM3R

LyMa101

Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer

Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC)

A Study Describing Real-World Effectiveness of Nivolumab + Chemotherapy in Neoadjuvant NSCLC

CheckMate 816

Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy